104 related articles for article (PubMed ID: 10848787)
1. Hypermethylation of P16ink4a and P15ink4b genes as a marker of disease in the follow-up of non-Hodgkin's lymphomas.
Martinez-Delgado B; Richart A; García MJ; Robledo M; Osorio A; Cebrian A; Rivas C; Benitez J
Br J Haematol; 2000 Apr; 109(1):97-103. PubMed ID: 10848787
[TBL] [Abstract][Full Text] [Related]
2. Different incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin's and CD30-Positive non-Hodgkin's lymphomas.
García MJ; Martínez-Delgado B; Cebrian A; Martínez A; Benítez J; Rivas C
Am J Pathol; 2002 Sep; 161(3):1007-13. PubMed ID: 12213729
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated among non-Hodgkin's lymphomas.
Martinez-Delgado B; Robledo M; Arranz E; Osorio A; García MJ; Echezarreta G; Rivas C; Benitez J
Leukemia; 1998 Jun; 12(6):937-41. PubMed ID: 9639423
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
[TBL] [Abstract][Full Text] [Related]
5. Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas.
Gombart AF; Morosetti R; Miller CW; Said JW; Koeffler HP
Blood; 1995 Aug; 86(4):1534-9. PubMed ID: 7632961
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas.
Malumbres M; Pérez de Castro I; Santos J; Meléndez B; Mangues R; Serrano M; Pellicer A; Fernández-Piqueras J
Oncogene; 1997 Mar; 14(11):1361-70. PubMed ID: 9178896
[TBL] [Abstract][Full Text] [Related]
7. Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas.
Zhuang SM; Schippert A; Haugen-Strano A; Wiseman RW; Söderkvist P
Oncogene; 1998 Feb; 16(6):803-8. PubMed ID: 9488045
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.
Herman JG; Civin CI; Issa JP; Collector MI; Sharkis SJ; Baylin SB
Cancer Res; 1997 Mar; 57(5):837-41. PubMed ID: 9041182
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies.
Hangaishi A; Ogawa S; Imamura N; Miyawaki S; Miura Y; Uike N; Shimazaki C; Emi N; Takeyama K; Hirosawa S; Kamada N; Kobayashi Y; Takemoto Y; Kitani T; Toyama K; Ohtake S; Yazaki Y; Ueda R; Hirai H
Blood; 1996 Jun; 87(12):4949-58. PubMed ID: 8652807
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.
Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A
Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma.
Martinez-Delgado B; Fernandez-Piqueras J; Garcia MJ; Arranz E; Gallego J; Rivas C; Robledo M; Benitez J
Leukemia; 1997 Mar; 11(3):425-8. PubMed ID: 9067584
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a novel human B-cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes.
Nagai M; Fujita M; Ohmori M; Matsubara S; Taniwaki M; Horiike S; Tasaka T; Koeffler HP; Takahara J
Hematol Oncol; 1997 Aug; 15(3):109-19. PubMed ID: 9600110
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma.
Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS
Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333
[TBL] [Abstract][Full Text] [Related]
16. Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease.
García JF; Villuendas R; Algara P; Sáez AI; Sánchez-Verde L; Martínez-Montero JC; Martínez P; Piris MA
Lab Invest; 1999 Dec; 79(12):1453-9. PubMed ID: 10616196
[TBL] [Abstract][Full Text] [Related]
17. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A
Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444
[TBL] [Abstract][Full Text] [Related]
18. Cumulation of TP53 mutations and p16INK4A/p15INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer.
Güran S; Pak I
Cancer Genet Cytogenet; 1999 Mar; 109(2):108-13. PubMed ID: 10087941
[TBL] [Abstract][Full Text] [Related]
19. Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes.
Aoki E; Uchida T; Ohashi H; Nagai H; Murase T; Ichikawa A; Yamao K; Hotta T; Kinoshita T; Saito H; Murate T
Leukemia; 2000 Apr; 14(4):586-93. PubMed ID: 10764143
[TBL] [Abstract][Full Text] [Related]
20. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
